110 related articles for article (PubMed ID: 9216658)
1. In vitro characterisation of soft tissue tumor chemosensitivity.
Remmelink M; Salmon I; Delville JP; Goldschmidt D; Capel P; Gebhart M; Pasteels JL; Kiss R; Darro F
Anticancer Res; 1997; 17(3C):2009-17. PubMed ID: 9216658
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-I receptor activation blocks doxorubicin cytotoxicity in sarcoma cells.
Beech DJ; Perer E; Helms J; Gratzer A; Deng N
Oncol Rep; 2003; 10(1):181-4. PubMed ID: 12469167
[TBL] [Abstract][Full Text] [Related]
3. [Synergistic effect of toremifene and cisplatin on human lung cancer cell line A549].
Zhang X; Li Q; Han Y; Liu Z
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):537-9. PubMed ID: 12667319
[TBL] [Abstract][Full Text] [Related]
4. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
Tyagi AK; Agarwal C; Chan DC; Agarwal R
Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
[TBL] [Abstract][Full Text] [Related]
5. In vitro chemosensitivity of human soft tissue sarcoma.
Morioka H; Yabe H; Morii T; Yamada R; Kato S; Yuasa S; Yano T
Anticancer Res; 2001; 21(6A):4147-51. PubMed ID: 11911309
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
[TBL] [Abstract][Full Text] [Related]
7. [In vitro modulation of adriamycin-induced cytotoxicity of fulerol C60(OH)24].
Puhaca B
Med Pregl; 1999; 52(11-12):521-6. PubMed ID: 10748779
[TBL] [Abstract][Full Text] [Related]
8. [Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
Li EX; Zhang YT; Shang JT; Xu Z; Geng Y; Li SM; Shi F; Wu YY
Ai Zheng; 2006 Aug; 25(8):1048-51. PubMed ID: 16965692
[TBL] [Abstract][Full Text] [Related]
9. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
10. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
11. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
[TBL] [Abstract][Full Text] [Related]
12. Chemosensitivity of breast cancer lymph node metastasis compared to the primary tumor from individual patients tested in the histoculture drug response assay.
Furukawa T; Kubota T; Tanino H; Oura S; Yuasa S; Murate H; Morita K; Kozakai K; Yano T; Hoffman RM
Anticancer Res; 2000; 20(5C):3657-8. PubMed ID: 11268434
[TBL] [Abstract][Full Text] [Related]
13. [A study of the effect of anti-tumor agents combined with caffeine on established lines of human osteosarcoma cells and primary cultured human sarcoma cells by clonogenic assay].
Tsuchiya H; Tomita K
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2269-75. PubMed ID: 3475041
[TBL] [Abstract][Full Text] [Related]
14. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
15. Bovine seminal ribonuclease exerts selective cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs.
Cinatl J; Cinatl J; Kotchetkov R; Matousek J; Woodcock BG; Koehl U; Vogel JU; Kornhuber B; Schwabe D
Anticancer Res; 2000; 20(2A):853-9. PubMed ID: 10810366
[TBL] [Abstract][Full Text] [Related]
16. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].
Hu S; Hu CP; Liang CH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030
[TBL] [Abstract][Full Text] [Related]
17. A chemosensitivity test for superficial bladder cancer based on three-dimensional culture of tumour spheroids.
Burgués JP; Gómez L; Pontones JL; Vera CD; Jiménez-Cruz JF; Ozonas M
Eur Urol; 2007 Apr; 51(4):962-9; discussion 969-70. PubMed ID: 17084017
[TBL] [Abstract][Full Text] [Related]
18. [Enhanced sensitivity of ovarian cell line to cisplatin induced by mifepristone and its mechanism].
Qin TN; Wang LL
Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):344-6. PubMed ID: 12390742
[TBL] [Abstract][Full Text] [Related]
19. Anticancer chemosensitivity profiles of human breast cancer cells assessed by in vitro DNA synthesis inhibition assay.
Nio Y; Tamura K; Kan N; Inamoto T; Ohgaki K; Kodama H
Anticancer Res; 2000; 20(2B):1237-44. PubMed ID: 10810427
[TBL] [Abstract][Full Text] [Related]
20. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
